ID   SET1_YEAST              Reviewed;        1080 AA.
AC   P38827; D3DL69;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   18-JUN-2025, entry version 210.
DE   RecName: Full=Histone-lysine N-methyltransferase, H3 lysine-4 specific {ECO:0000303|PubMed:11805083};
DE            EC=2.1.1.354 {ECO:0000269|PubMed:11805083, ECO:0000305|PubMed:29071121};
DE   AltName: Full=COMPASS component SET1 {ECO:0000303|PubMed:11742990};
DE   AltName: Full=Lysine N-methyltransferase 2;
DE   AltName: Full=SET domain-containing protein 1 {ECO:0000303|PubMed:11742990};
GN   Name=SET1 {ECO:0000303|PubMed:9398665};
GN   Synonyms=KMT2 {ECO:0000303|PubMed:18022353}, YTX1;
GN   OrderedLocusNames=YHR119W;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=8091229; DOI=10.1126/science.8091229;
RA   Johnston M., Andrews S., Brinkman R., Cooper J., Ding H., Dover J., Du Z.,
RA   Favello A., Fulton L., Gattung S., Geisel C., Kirsten J., Kucaba T.,
RA   Hillier L.W., Jier M., Johnston L., Langston Y., Latreille P., Louis E.J.,
RA   Macri C., Mardis E., Menezes S., Mouser L., Nhan M., Rifkin L., Riles L.,
RA   St Peter H., Trevaskis E., Vaughan K., Vignati D., Wilcox L., Wohldman P.,
RA   Waterston R., Wilson R., Vaudin M.;
RT   "Complete nucleotide sequence of Saccharomyces cerevisiae chromosome
RT   VIII.";
RL   Science 265:2077-2082(1994).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [3]
RP   FUNCTION.
RX   PubMed=9398665; DOI=10.1091/mbc.8.12.2421;
RA   Nislow C., Ray E., Pillus L.;
RT   "SET1, a yeast member of the Trithorax family, functions in transcriptional
RT   silencing and diverse cellular processes.";
RL   Mol. Biol. Cell 8:2421-2436(1997).
RN   [4]
RP   FUNCTION, AND INTERACTION WITH MEC3.
RX   PubMed=9988274; DOI=10.1038/5991;
RA   Corda Y., Schramke V., Longhese M.P., Smokvina T., Paciotti V., Brevet V.,
RA   Gilson E., Geli V.;
RT   "Interaction between Set1p and checkpoint protein Mec3p in DNA repair and
RT   telomere functions.";
RL   Nat. Genet. 21:204-208(1999).
RN   [5]
RP   IDENTIFICATION IN THE SET1C/COMPASS COMPLEX, AND FUNCTION OF THE SET1
RP   COMPLEX.
RX   PubMed=11742990; DOI=10.1093/emboj/20.24.7137;
RA   Roguev A., Schaft D., Shevchenko A., Pijnappel W.W.M.P., Wilm M.,
RA   Aasland R., Stewart A.F.;
RT   "The Saccharomyces cerevisiae Set1 complex includes an Ash2 homologue and
RT   methylates histone 3 lysine 4.";
RL   EMBO J. 20:7137-7148(2001).
RN   [6]
RP   FUNCTION.
RX   PubMed=11751634; DOI=10.1101/gad.940201;
RA   Briggs S.D., Bryk M., Strahl B.D., Cheung W.L., Davie J.K., Dent S.Y.R.,
RA   Winston F., Allis C.D.;
RT   "Histone H3 lysine 4 methylation is mediated by Set1 and required for cell
RT   growth and rDNA silencing in Saccharomyces cerevisiae.";
RL   Genes Dev. 15:3286-3295(2001).
RN   [7]
RP   SUBUNIT.
RX   PubMed=11687631; DOI=10.1073/pnas.231473398;
RA   Miller T., Krogan N.J., Dover J., Erdjument-Bromage H., Tempst P.,
RA   Johnston M., Greenblatt J.F., Shilatifard A.;
RT   "COMPASS: a complex of proteins associated with a trithorax-related SET
RT   domain protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:12902-12907(2001).
RN   [8]
RP   FUNCTION.
RX   PubMed=11818070; DOI=10.1016/s0960-9822(01)00652-2;
RA   Bryk M., Briggs S.D., Strahl B.D., Curcio M.J., Allis C.D., Winston F.;
RT   "Evidence that Set1, a factor required for methylation of histone H3,
RT   regulates rDNA silencing in S. cerevisiae by a Sir2-independent
RT   mechanism.";
RL   Curr. Biol. 12:165-170(2002).
RN   [9]
RP   CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=11805083; DOI=10.1074/jbc.c200023200;
RA   Krogan N.J., Dover J., Khorrami S., Greenblatt J.F., Schneider J.,
RA   Johnston M., Shilatifard A.;
RT   "COMPASS, a histone H3 (Lysine 4) methyltransferase required for telomeric
RT   silencing of gene expression.";
RL   J. Biol. Chem. 277:10753-10755(2002).
RN   [10]
RP   FUNCTION.
RX   PubMed=12353038; DOI=10.1038/nature01080;
RA   Santos-Rosa H., Schneider R., Bannister A.J., Sherriff J., Bernstein B.E.,
RA   Emre N.C.T., Schreiber S.L., Mellor J., Kouzarides T.;
RT   "Active genes are tri-methylated at K4 of histone H3.";
RL   Nature 419:407-411(2002).
RN   [11]
RP   IDENTIFICATION IN THE SET1C/COMPASS COMPLEX, AND FUNCTION OF THE SET1
RP   COMPLEX.
RX   PubMed=11752412; DOI=10.1073/pnas.221596698;
RA   Nagy P.L., Griesenbeck J., Kornberg R.D., Cleary M.L.;
RT   "A trithorax-group complex purified from Saccharomyces cerevisiae is
RT   required for methylation of histone H3.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:90-94(2002).
RN   [12]
RP   FUNCTION.
RX   PubMed=12060701; DOI=10.1073/pnas.082249499;
RA   Bernstein B.E., Humphrey E.L., Erlich R.L., Schneider R., Bouman P.,
RA   Liu J.S., Kouzarides T., Schreiber S.L.;
RT   "Methylation of histone H3 Lys 4 in coding regions of active genes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:8695-8700(2002).
RN   [13]
RP   FUNCTION.
RX   PubMed=14636589; DOI=10.1016/s1097-2765(03)00438-6;
RA   Santos-Rosa H., Schneider R., Bernstein B.E., Karabetsou N., Morillon A.,
RA   Weise C., Schreiber S.L., Mellor J., Kouzarides T.;
RT   "Methylation of histone H3 K4 mediates association of the Isw1p ATPase with
RT   chromatin.";
RL   Mol. Cell 12:1325-1332(2003).
RN   [14]
RP   ERRATUM OF PUBMED:14636589.
RX   PubMed=29883612; DOI=10.1016/j.molcel.2018.05.012;
RA   Santos-Rosa H., Schneider R., Bernstein B.E., Karabetsou N., Morillon A.,
RA   Weise C., Schreiber S.L., Mellor J., Kouzarides T.;
RL   Mol. Cell 70:983-983(2018).
RN   [15]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [16]
RP   FUNCTION.
RX   PubMed=12845608; DOI=10.1002/yea.995;
RA   Boa S., Coert C., Patterton H.-G.;
RT   "Saccharomyces cerevisiae Set1p is a methyltransferase specific for lysine
RT   4 of histone H3 and is required for efficient gene expression.";
RL   Yeast 20:827-835(2003).
RN   [17]
RP   FUNCTION OF THE COMPASS COMPLEX.
RX   PubMed=15949446; DOI=10.1016/j.molcel.2005.05.009;
RA   Morillon A., Karabetsou N., Nair A., Mellor J.;
RT   "Dynamic lysine methylation on histone H3 defines the regulatory phase of
RT   gene transcription.";
RL   Mol. Cell 18:723-734(2005).
RN   [18]
RP   NOMENCLATURE.
RX   PubMed=18022353; DOI=10.1016/j.cell.2007.10.039;
RA   Allis C.D., Berger S.L., Cote J., Dent S., Jenuwien T., Kouzarides T.,
RA   Pillus L., Reinberg D., Shi Y., Shiekhattar R., Shilatifard A., Workman J.,
RA   Zhang Y.;
RT   "New nomenclature for chromatin-modifying enzymes.";
RL   Cell 131:633-636(2007).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-625, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ADR376;
RX   PubMed=17330950; DOI=10.1021/pr060559j;
RA   Li X., Gerber S.A., Rudner A.D., Beausoleil S.A., Haas W., Villen J.,
RA   Elias J.E., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of alpha-factor-arrested
RT   Saccharomyces cerevisiae.";
RL   J. Proteome Res. 6:1190-1197(2007).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-625 AND THR-875, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19779198; DOI=10.1126/science.1172867;
RA   Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.;
RT   "Global analysis of Cdk1 substrate phosphorylation sites provides insights
RT   into evolution.";
RL   Science 325:1682-1686(2009).
RN   [21]
RP   FUNCTION, CATALYTIC ACTIVITY, IDENTIFICATION IN THE SET1C/COMPASS COMPLEX,
RP   SUBCELLULAR LOCATION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF
RP   271-TYR-PHE-272.
RX   PubMed=29071121; DOI=10.1038/celldisc.2017.40;
RA   Luciano P., Jeon J., El-Kaoutari A., Challal D., Bonnet A., Barucco M.,
RA   Candelli T., Jourquin F., Lesage P., Kim J., Libri D., Geli V.;
RT   "Binding to RNA regulates Set1 function.";
RL   Cell Discov. 3:17040-17040(2017).
RN   [22] {ECO:0007744|PDB:2J8A}
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 247-375, FUNCTION, IDENTIFICATION
RP   IN THE SET1C/COMPASS COMPLEX, AND MUTAGENESIS OF 271-TYR-PHE-272 AND
RP   HIS-422.
RX   PubMed=16787775; DOI=10.1016/j.jmb.2006.04.050;
RA   Tresaugues L., Dehe P.M., Guerois R., Rodriguez-Gil A., Varlet I.,
RA   Salah P., Pamblanco M., Luciano P., Quevillon-Cheruel S., Sollier J.,
RA   Leulliot N., Couprie J., Tordera V., Zinn-Justin S., Chavez S.,
RA   van Tilbeurgh H., Geli V.;
RT   "Structural characterization of Set1 RNA recognition motifs and their role
RT   in histone H3 lysine 4 methylation.";
RL   J. Mol. Biol. 359:1170-1181(2006).
RN   [23] {ECO:0007744|PDB:6VEN}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.37 ANGSTROMS) OF 762-1080 WITHIN THE
RP   CORE COMPASS H2B-UBIQUITIN NUCLEOSOME COMPLEX, SUBUNIT, DOMAIN, AND
RP   FUNCTION.
RX   PubMed=31922488; DOI=10.7554/elife.53199;
RA   Worden E.J., Zhang X., Wolberger C.;
RT   "Structural basis for COMPASS recognition of an H2B-ubiquitinated
RT   nucleosome.";
RL   Elife 9:e53199-e53199(2020).
CC   -!- FUNCTION: Catalytic component of the COMPASS (Set1C) complex that
CC       specifically mono-, di- and trimethylates histone H3 to form
CC       H3K4me1/2/3 (PubMed:11742990, PubMed:11751634, PubMed:11752412,
CC       PubMed:11805083, PubMed:11818070, PubMed:12060701, PubMed:12353038,
CC       PubMed:12845608, PubMed:14636589, PubMed:15949446, PubMed:29071121).
CC       Binds RNAs involved in chromosome segregation, splicing and
CC       transcriptional regulation; appears to bind transcripts both co- and
CC       post-transcriptionally and binding might negatively affect its histone
CC       methyltransferase activity (PubMed:16787775, PubMed:29071121). COMPASS
CC       recognizes ubiquitinated H2B on one face of the nucleosome which
CC       stimulates the methylation of H3 on the opposing face
CC       (PubMed:31922488). Plays a role in telomere length maintenance and
CC       transcription elongation regulation (PubMed:11742990, PubMed:11751634,
CC       PubMed:11805083, PubMed:11818070, PubMed:14636589, PubMed:15949446,
CC       PubMed:9398665, PubMed:9988274). {ECO:0000269|PubMed:11742990,
CC       ECO:0000269|PubMed:11751634, ECO:0000269|PubMed:11752412,
CC       ECO:0000269|PubMed:11805083, ECO:0000269|PubMed:11818070,
CC       ECO:0000269|PubMed:12060701, ECO:0000269|PubMed:12353038,
CC       ECO:0000269|PubMed:12845608, ECO:0000269|PubMed:14636589,
CC       ECO:0000269|PubMed:15949446, ECO:0000269|PubMed:16787775,
CC       ECO:0000269|PubMed:18022353, ECO:0000269|PubMed:29071121,
CC       ECO:0000269|PubMed:31922488, ECO:0000269|PubMed:9398665,
CC       ECO:0000269|PubMed:9988274}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-lysyl(4)-[histone H3] + 3 S-adenosyl-L-methionine =
CC         N(6),N(6),N(6)-trimethyl-L-lysyl(4)-[histone H3] + 3 S-adenosyl-L-
CC         homocysteine + 3 H(+); Xref=Rhea:RHEA:60260, Rhea:RHEA-COMP:15537,
CC         Rhea:RHEA-COMP:15547, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:61961;
CC         EC=2.1.1.354; Evidence={ECO:0000269|PubMed:11805083,
CC         ECO:0000305|PubMed:29071121};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(6)-methyl-L-lysyl(4)-[histone H3] + S-adenosyl-L-methionine
CC         = N(6),N(6)-dimethyl-L-lysyl(4)-[histone H3] + S-adenosyl-L-
CC         homocysteine + H(+); Xref=Rhea:RHEA:60268, Rhea:RHEA-COMP:15540,
CC         Rhea:RHEA-COMP:15543, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789, ChEBI:CHEBI:61929, ChEBI:CHEBI:61976;
CC         Evidence={ECO:0000269|PubMed:12353038, ECO:0000305|PubMed:29071121};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(6),N(6)-dimethyl-L-lysyl(4)-[histone H3] + S-adenosyl-L-
CC         methionine = N(6),N(6),N(6)-trimethyl-L-lysyl(4)-[histone H3] + S-
CC         adenosyl-L-homocysteine + H(+); Xref=Rhea:RHEA:60272, Rhea:RHEA-
CC         COMP:15537, Rhea:RHEA-COMP:15540, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:61961,
CC         ChEBI:CHEBI:61976; Evidence={ECO:0000269|PubMed:12353038,
CC         ECO:0000305|PubMed:29071121};
CC   -!- SUBUNIT: Component of the Set1C/COMPASS complex which consists of
CC       SET1(2), BRE2(2), SPP1(2), SDC1(1), SHG1(1), SWD1(1), SWD2(1), and
CC       SWD3(1) (PubMed:11687631, PubMed:11742990, PubMed:11752412,
CC       PubMed:16787775, PubMed:29071121, PubMed:31922488). Interacts with MEC3
CC       (PubMed:9988274). {ECO:0000269|PubMed:11687631,
CC       ECO:0000269|PubMed:11742990, ECO:0000269|PubMed:11752412,
CC       ECO:0000269|PubMed:16787775, ECO:0000269|PubMed:29071121,
CC       ECO:0000269|PubMed:31922488, ECO:0000269|PubMed:9988274}.
CC   -!- INTERACTION:
CC       P38827; P43132: BRE2; NbExp=8; IntAct=EBI-16977, EBI-27115;
CC       P38827; Q02574: MEC3; NbExp=3; IntAct=EBI-16977, EBI-10658;
CC       P38827; P38337: SHG1; NbExp=6; IntAct=EBI-16977, EBI-21106;
CC       P38827; P0CS90: SSC1; NbExp=2; IntAct=EBI-16977, EBI-8637;
CC       P38827; P36104: SWD2; NbExp=7; IntAct=EBI-16977, EBI-26608;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:29071121}. Chromosome
CC       {ECO:0000269|PubMed:29071121}. Note=Localizes to the 5' region of
CC       active genes transcribed by RNAPII. {ECO:0000269|PubMed:29071121}.
CC   -!- DOMAIN: The RxxxRR motif forms an adapter helix that bridges the
CC       nucleosome acidic patch and ubiquitin from ubiquitinated histone H2B
CC       which is critical for COMPASS activity. {ECO:0000269|PubMed:31922488}.
CC   -!- DISRUPTION PHENOTYPE: Abolishes cellular H3K4 mono-, di- and
CC       trimethylation (PubMed:29071121). Increases the frequency of Ty1
CC       retrotransposition (PubMed:29071121). {ECO:0000269|PubMed:29071121}.
CC   -!- MISCELLANEOUS: Present with 172 molecules/cell in log phase SD medium.
CC       {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the class V-like SAM-binding methyltransferase
CC       superfamily. {ECO:0000255|PROSITE-ProRule:PRU00190}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U00059; AAB68867.1; -; Genomic_DNA.
DR   EMBL; BK006934; DAA06813.1; -; Genomic_DNA.
DR   PIR; S48961; S48961.
DR   RefSeq; NP_011987.1; NM_001179249.1.
DR   PDB; 2J8A; X-ray; 3.00 A; A=247-375.
DR   PDB; 6VEN; EM; 3.37 A; N=762-1080.
DR   PDBsum; 2J8A; -.
DR   PDBsum; 6VEN; -.
DR   AlphaFoldDB; P38827; -.
DR   EMDB; EMD-21157; -.
DR   SMR; P38827; -.
DR   BioGRID; 36552; 500.
DR   ComplexPortal; CPX-1039; COMPASS complex.
DR   DIP; DIP-4616N; -.
DR   ELM; P38827; -.
DR   FunCoup; P38827; 196.
DR   IntAct; P38827; 38.
DR   MINT; P38827; -.
DR   STRING; 4932.YHR119W; -.
DR   GlyGen; P38827; 1 site.
DR   iPTMnet; P38827; -.
DR   PaxDb; 4932-YHR119W; -.
DR   PeptideAtlas; P38827; -.
DR   EnsemblFungi; YHR119W_mRNA; YHR119W; YHR119W.
DR   GeneID; 856519; -.
DR   KEGG; sce:YHR119W; -.
DR   AGR; SGD:S000001161; -.
DR   SGD; S000001161; SET1.
DR   VEuPathDB; FungiDB:YHR119W; -.
DR   eggNOG; KOG1080; Eukaryota.
DR   GeneTree; ENSGT00940000169211; -.
DR   HOGENOM; CLU_004391_1_0_1; -.
DR   InParanoid; P38827; -.
DR   OMA; ERLPCLC; -.
DR   OrthoDB; 308383at2759; -.
DR   BioCyc; YEAST:G3O-31161-MONOMER; -.
DR   Reactome; R-SCE-3214841; PKMTs methylate histone lysines.
DR   Reactome; R-SCE-9772755; Formation of WDR5-containing histone-modifying complexes.
DR   BioGRID-ORCS; 856519; 0 hits in 10 CRISPR screens.
DR   EvolutionaryTrace; P38827; -.
DR   PRO; PR:P38827; -.
DR   Proteomes; UP000002311; Chromosome VIII.
DR   RNAct; P38827; protein.
DR   GO; GO:0000781; C:chromosome, telomeric region; IGI:ARUK-UCL.
DR   GO; GO:0005634; C:nucleus; NAS:ComplexPortal.
DR   GO; GO:0048188; C:Set1C/COMPASS complex; IDA:UniProtKB.
DR   GO; GO:0042800; F:histone H3K4 methyltransferase activity; IMP:CACAO.
DR   GO; GO:0140999; F:histone H3K4 trimethyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016279; F:protein-lysine N-methyltransferase activity; IMP:SGD.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0030437; P:ascospore formation; IMP:SGD.
DR   GO; GO:0033554; P:cellular response to stress; IMP:SGD.
DR   GO; GO:0042138; P:meiotic DNA double-strand break formation; IMP:SGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:CACAO.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:SGD.
DR   GO; GO:1905088; P:positive regulation of synaptonemal complex assembly; IMP:CACAO.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:SGD.
DR   GO; GO:0006479; P:protein methylation; IMP:CACAO.
DR   GO; GO:0000183; P:rDNA heterochromatin formation; IMP:CACAO.
DR   GO; GO:1902275; P:regulation of chromatin organization; IMP:SGD.
DR   GO; GO:1903341; P:regulation of meiotic DNA double-strand break formation; IMP:SGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IMP:SGD.
DR   GO; GO:0030466; P:silent mating-type cassette heterochromatin formation; IMP:SGD.
DR   GO; GO:0055092; P:sterol homeostasis; IMP:CACAO.
DR   GO; GO:0031509; P:subtelomeric heterochromatin formation; IMP:SGD.
DR   GO; GO:0007130; P:synaptonemal complex assembly; IMP:CACAO.
DR   GO; GO:0000723; P:telomere maintenance; IMP:SGD.
DR   CDD; cd12302; RRM_scSet1p_like; 1.
DR   CDD; cd20072; SET_SET1; 1.
DR   FunFam; 2.170.270.10:FF:000056; Histone-lysine N-methyltransferase, H3 lysine-4 specific; 1.
DR   Gene3D; 3.30.70.330; -; 1.
DR   Gene3D; 2.170.270.10; SET domain; 1.
DR   InterPro; IPR024657; COMPASS_Set1_N-SET.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR003616; Post-SET_dom.
DR   InterPro; IPR044570; Set1-like.
DR   InterPro; IPR017111; Set1_fungi.
DR   InterPro; IPR048669; SET1_RBD.
DR   InterPro; IPR024636; SET_assoc.
DR   InterPro; IPR001214; SET_dom.
DR   InterPro; IPR046341; SET_dom_sf.
DR   PANTHER; PTHR45814; HISTONE-LYSINE N-METHYLTRANSFERASE SETD1; 1.
DR   PANTHER; PTHR45814:SF2; HISTONE-LYSINE N-METHYLTRANSFERASE SETD1; 1.
DR   Pfam; PF11764; N-SET; 1.
DR   Pfam; PF00856; SET; 1.
DR   Pfam; PF21569; SET1_RBD; 1.
DR   Pfam; PF11767; SET_assoc; 1.
DR   PIRSF; PIRSF037104; Histone_H3-K4_mtfrase_Set1_fun; 1.
DR   SMART; SM01291; N-SET; 1.
DR   SMART; SM00508; PostSET; 1.
DR   SMART; SM00317; SET; 1.
DR   SUPFAM; SSF82199; SET domain; 1.
DR   PROSITE; PS50868; POST_SET; 1.
DR   PROSITE; PS51572; SAM_MT43_1; 1.
DR   PROSITE; PS50280; SET; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chromatin regulator; Chromosome; Methyltransferase; Nucleus;
KW   Phosphoprotein; Reference proteome; S-adenosyl-L-methionine; Transferase.
FT   CHAIN           1..1080
FT                   /note="Histone-lysine N-methyltransferase, H3 lysine-4
FT                   specific"
FT                   /id="PRO_0000186086"
FT   DOMAIN          938..1055
FT                   /note="SET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT   DOMAIN          1064..1080
FT                   /note="Post-SET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00155"
FT   REGION          1..230
FT                   /note="Binds SWD2"
FT                   /evidence="ECO:0000269|PubMed:29071121"
FT   REGION          1..46
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          54..73
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          78..121
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          230..569
FT                   /note="Binds RNA"
FT                   /evidence="ECO:0000269|PubMed:16787775,
FT                   ECO:0000269|PubMed:29071121"
FT   REGION          356..569
FT                   /note="Binds SHG1"
FT                   /evidence="ECO:0000269|PubMed:29071121"
FT   REGION          646..729
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          762..938
FT                   /note="Binds SPP1"
FT                   /evidence="ECO:0000269|PubMed:29071121"
FT   REGION          762..938
FT                   /note="Contributes to RNA binding"
FT                   /evidence="ECO:0000269|PubMed:29071121"
FT   REGION          762..938
FT                   /note="Required for catalytic activity"
FT                   /evidence="ECO:0000269|PubMed:29071121"
FT   REGION          877..909
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           904..909
FT                   /note="RxxxRR motif"
FT                   /evidence="ECO:0000269|PubMed:31922488,
FT                   ECO:0007744|PDB:6VEN"
FT   COMPBIAS        11..28
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        29..46
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        54..67
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        78..87
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        99..121
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        674..692
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        693..712
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        877..890
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        899..909
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         1054
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00190"
FT   MOD_RES         625
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17330950,
FT                   ECO:0007744|PubMed:19779198"
FT   MOD_RES         875
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:19779198"
FT   MUTAGEN         271..272
FT                   /note="YF->AA: Increases its histone methyltransferase
FT                   activity. Strongly decreases binding to the majority of its
FT                   RNA targets; binding to Ty1 retrotransposon mRNA is not
FT                   affected. Decreases cellular H3K4me2/3 levels. Decreases
FT                   occupancy of the protein in the 5' region of genes, and
FT                   increases its occupancy in the 3'-end of genes. Decreases
FT                   the level of SET1 protein in the cell. Does not affect the
FT                   frequency of Ty1 retrotransposition."
FT                   /evidence="ECO:0000269|PubMed:16787775,
FT                   ECO:0000269|PubMed:29071121"
FT   MUTAGEN         422
FT                   /note="H->A: Strongly decreases RNA binding. Does not
FT                   affect cellular H3K4me2/3 levels."
FT                   /evidence="ECO:0000269|PubMed:16787775"
FT   STRAND          249..258
FT                   /evidence="ECO:0007829|PDB:2J8A"
FT   HELIX           265..273
FT                   /evidence="ECO:0007829|PDB:2J8A"
FT   STRAND          279..285
FT                   /evidence="ECO:0007829|PDB:2J8A"
FT   TURN            287..289
FT                   /evidence="ECO:0007829|PDB:2J8A"
FT   STRAND          292..299
FT                   /evidence="ECO:0007829|PDB:2J8A"
FT   HELIX           310..320
FT                   /evidence="ECO:0007829|PDB:2J8A"
FT   TURN            321..324
FT                   /evidence="ECO:0007829|PDB:2J8A"
FT   STRAND          326..328
FT                   /evidence="ECO:0007829|PDB:2J8A"
FT   STRAND          331..337
FT                   /evidence="ECO:0007829|PDB:2J8A"
FT   HELIX           342..364
FT                   /evidence="ECO:0007829|PDB:2J8A"
FT   HELIX           804..824
FT                   /evidence="ECO:0007829|PDB:6VEN"
FT   STRAND          835..837
FT                   /evidence="ECO:0007829|PDB:6VEN"
FT   HELIX           900..917
FT                   /evidence="ECO:0007829|PDB:6VEN"
FT   HELIX           918..920
FT                   /evidence="ECO:0007829|PDB:6VEN"
FT   STRAND          940..944
FT                   /evidence="ECO:0007829|PDB:6VEN"
FT   STRAND          946..956
FT                   /evidence="ECO:0007829|PDB:6VEN"
FT   STRAND          963..966
FT                   /evidence="ECO:0007829|PDB:6VEN"
FT   STRAND          969..972
FT                   /evidence="ECO:0007829|PDB:6VEN"
FT   HELIX           974..986
FT                   /evidence="ECO:0007829|PDB:6VEN"
FT   STRAND          994..998
FT                   /evidence="ECO:0007829|PDB:6VEN"
FT   STRAND          1001..1009
FT                   /evidence="ECO:0007829|PDB:6VEN"
FT   HELIX           1011..1014
FT                   /evidence="ECO:0007829|PDB:6VEN"
FT   STRAND          1022..1030
FT                   /evidence="ECO:0007829|PDB:6VEN"
FT   STRAND          1033..1042
FT                   /evidence="ECO:0007829|PDB:6VEN"
SQ   SEQUENCE   1080 AA;  123912 MW;  B7FA5D60F71063FD CRC64;
     MSNYYRRAHA SSGSYRQPQE QPQYSRSGHY QYSNGHSHQQ YSSQYNQRRR YNHNDGTRRR
     YNDDRPHSSN NASTRQYYAT NNSQSGPYVN KKSDISSRRG MSQSRYSNSN VHNTLASSSG
     SLPTESALLL QQRPPSVLRY NTDNLKSKFH YFDPIKGEFF NKDKMLSWKA TDKEFSETGY
     YVVKELQDGQ FKFKIKHRHP EIKASDPRNE NGIMTSGKVA THRKCRNSLI LLPRISYDRY
     SLGPPPSCEI VVYPAQDSTT TNIQDISIKN YFKKYGEISH FEAFNDPNSA LPLHVYLIKY
     ASSDGKINDA AKAAFSAVRK HESSGCFIMG FKFEVILNKH SILNNIISKF VEINVKKLQK
     LQENLKKAKE KEAENEKAKE LQGKDITLPK EPKVDTLSHS SGSEKRIPYD LLGVVNNRPV
     LHVSKIFVAK HRFCVEDFKY KLRGYRCAKF IDHPTGIYII FNDIAHAQTC SNAESGNLTI
     MSRSRRIPIL IKFHLILPRF QNRTRFNKSS SSSNSTNVPI KYESKEEFIE ATAKQILKDL
     EKTLHVDIKK RLIGPTVFDA LDHANFPELL AKRELKEKEK RQQIASKIAE DELKRKEEAK
     RDFDLFGLYG GYAKSNKRNL KRHNSLALDH TSLKRKKLSN GIKPMAHLLN EETDSKETTP
     LNDEGITRVS KEHDEEDENM TSSSSEEEEE EAPDKKFKSE SEPTTPESDH LHGIKPLVPD
     QNGSSDVLDA SSMYKPTATE IPEPVYPPEE YDLKYSQTLS SMDLQNAIKD EEDMLILKQL
     LSTYTPTVTP ETSAALEYKI WQSRRKVLEE EKASDWQIEL NGTLFDSELQ PGSSFKAEGF
     RKIADKLKIN YLPHRRRVHQ PLNTVNIHNE RNEYTPELCQ REESSNKEPS DSVPQEVSSS
     RDNRASNRRF QQDIEAQKAA IGTESELLSL NQLNKRKKPV MFARSAIHNW GLYALDSIAA
     KEMIIEYVGE RIRQPVAEMR EKRYLKNGIG SSYLFRVDEN TVIDATKKGG IARFINHCCD
     PNCTAKIIKV GGRRRIVIYA LRDIAASEEL TYDYKFEREK DDEERLPCLC GAPNCKGFLN
//
